Promising prophylactic means and methods for prevention of community-acquired pneumonia and respiratory infections among servicemen in Russia Source: Eur Respir J 2006; 28: Suppl. 50, 350s Year: 2006
Trends in empiric antimicrobial therapy and efficiency of care for community-acquired pneumonia in hospitalized Belarussian patients Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia Year: 2007
Influence of adherence to clinical guidelines in empiric antibiotics choice on outcomes of community-acquired pneumonia in hospitalized Belarussian patients Source: Eur Respir J 2005; 26: Suppl. 49, 637s Year: 2005
Effectiveness of once daily meropenem for the treatment of aspiration pneumonia of elderly patients in long-term care facilities Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections Year: 2011
Microbiological testing of adults hospitalised with community-acquired pneumonia: an international study Source: ERJ Open Res, 4 (4) 00096-2018; 10.1183/23120541.00096-2018 Year: 2018
Costs of treatment of hospitalised community-acquired pneumonia from the hospitals’ perspective – a prospective study comparing moxifloxacin with other antibiotic treatment alternatives Source: Eur Respir J 2004; 24: Suppl. 48, 185s Year: 2004
Efficacy and safety of levofloxacin treatment of community-acquired pneumonia in hospitalized patients Source: Eur Respir J 2005; 26: Suppl. 49, 637s Year: 2005
Pneumococcal pneumonia in hospitalized patients. Therapeutic implications of resistances to penicillin and erythromycin Source: Eur Respir J 2003; 22: Suppl. 45, 543s Year: 2003
Antibiotic therapy of community-acquired pneumonia in the hospital setting: national guidelines and real clinical practice. Source: International Congress 2017 – COPD management Year: 2017
Antibiotic management of nosocomial pneumonia in children Source: Eur Respir J 2006; 28: Suppl. 50, 633s Year: 2006
Epidemiological impact of antibiotic use/misuse in the community Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=165 Year: 2004
The influence of modern microbiological methods on the antibiotic treatment of pneumonia in children Source: International Congress 2018 – Paediatric respiratory infections: mechanistic insights and clinical outcomes Year: 2018
Etiology and antimicrobial resistance of secondary bacterial infections in patients hospitalized with COVID-19 in Moscow city hospital Source: Virtual Congress 2021 – Burden and epidemiology of COVID-19 Year: 2021
Barriers to an early switch from intravenous to oral antibiotic therapy in hospitalised patients with CAP Source: Eur Respir J 2013; 41: 123-130 Year: 2013
Streptococcal pharyngotonsillitis in Italy. Clinical and bacteriological efficacy evaluation of various antibiotics Source: Eur Respir J 2002; 20: Suppl. 38, 159s Year: 2002
Aspiration risks factors, microbiology and empiric antibiotics for patients hospitalized with community-acquired pneumonia Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice Year: 2020
The causative agents of community–acquired pneumonia among servicemen of the Russian army Source: Eur Respir J 2004; 24: Suppl. 48, 364s Year: 2004
Efficacy and safety of azithromycin vs. clarithromycin for the treatment of community-acquired pneumonia due to legionella pneumophila Source: Annual Congress 2004 - Community acquired pneumonia - epidemiology and host defence Year: 2004
Simultaneous use of probiotics and vaccines for prevention of pneumonia and respiratory infections in servicemen Source: Eur Respir J 2006; 28: Suppl. 50, 154s Year: 2006
Pharmacoepidemiology of antibiotics using for treatment severe pulmonary infections in a clinical city hospital Source: Eur Respir J 2005; 26: Suppl. 49, 640s Year: 2005